BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36602428)

  • 1. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
    Xia P; Zhang H; Lu H; Xu K; Jiang X; Jiang Y; Gongye X; Chen Z; Liu J; Chen X; Ma W; Zhang Z; Yuan Y
    Cancer Commun (Lond); 2023 Mar; 43(3):338-364. PubMed ID: 36602428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The m6A methyltransferase METTL5 promotes neutrophil extracellular trap network release to regulate hepatocellular carcinoma progression.
    Wang Q; Huang Y; Zhu Y; Zhang W; Wang B; Du X; Dai Q; Zhang F; Fang Z
    Cancer Med; 2024 Apr; 13(7):e7165. PubMed ID: 38613157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The m6A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma.
    Zeng Z; Wang J; Xu F; Hu P; Hu Y; Zhuo W; Chen D; Han S; Wang F; Zhao Y; Huang Y; Zhao G
    Int J Biol Sci; 2024; 20(5):1744-1762. PubMed ID: 38481809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL5 promotes gastric cancer progression
    Zhang YQ; Li J; Qin Z; Li DM; Ye FZ; Bei SH; Zhang XH; Feng L
    World J Gastrointest Oncol; 2024 May; 16(5):1925-1946. PubMed ID: 38764837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPI1-reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis.
    Liu BHM; Tey SK; Mao X; Ma APY; Yeung CLS; Wong SWK; Ng TH; Xu Y; Yao Y; Fung EYM; Tan KV; Khong PL; Ho DW; Ng IO; Tang AHN; Cai SH; Yun JP; Yam JWP
    J Extracell Vesicles; 2021 Aug; 10(10):e12135. PubMed ID: 34401050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TFAIP6 facilitates hepatocellular carcinoma cell glycolysis through upregulating c-myc/PKM2 axis.
    Duan K; Fang K; Sui C
    Heliyon; 2024 May; 10(10):e30959. PubMed ID: 38813227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL5 promotes cell proliferation, invasion, and migration by up-regulating Toll-like receptor 8 expression in colorectal cancer.
    Kong LS; Tao R; Li YF; Wang WB; Zhao X
    World J Gastrointest Oncol; 2024 May; 16(5):2006-2017. PubMed ID: 38764815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear translocation of metabolic enzyme PKM2 participates in high glucose-promoted HCC metastasis by strengthening immunosuppressive environment.
    Qian J; Huang C; Wang M; Liu Y; Zhao Y; Li M; Zhang X; Gao X; Zhang Y; Wang Y; Huang J; Li J; Zhou Q; Liu R; Wang X; Cui J; Yang Y
    Redox Biol; 2024 May; 71():103103. PubMed ID: 38471282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGS19 activates the MYH9/╬▓-catenin/c-Myc positive feedback loop in hepatocellular carcinoma.
    Ke S; Lu S; Xu Y; Bai M; Yu H; Yin B; Wang C; Feng Z; Li Z; Huang J; Li X; Qian B; Hua Y; Fu Y; Sun B; Wu Y; Ma Y
    Exp Mol Med; 2024 Jun; ():. PubMed ID: 38825640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis.
    Chan TC; Chen YT; Tan KT; Wu CL; Wu WJ; Li WM; Wang JM; Shiue YL; Li CF
    Clin Transl Med; 2021 Dec; 11(12):e674. PubMed ID: 34954904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP5 facilitates diabetic retinopathy development by stabilizing ROBO4 via deubiquitination.
    Guo H; Liu R; Lv H; Huo Q; Yao Y; Lu X
    Cell Signal; 2024 Aug; 120():111225. PubMed ID: 38735506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer.
    Li M; Yu J; Ju L; Wang Y; Jin W; Zhang R; Xiang W; Ji M; Du W; Wang G; Qian K; Zhang Y; Xiao Y; Wang X
    Cell Death Dis; 2024 Jan; 15(1):44. PubMed ID: 38218970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP5 promotes tumorigenesis by activating Hedgehog/Gli1 signaling pathway in osteosarcoma.
    Wu Q; Liu R; Yang Y; Peng J; Huang J; Li Z; Huang K; Zhu X
    Am J Cancer Res; 2024; 14(3):1204-1216. PubMed ID: 38590401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of abnormal ubiquitination in hepatocellular carcinoma pathology.
    Zhang M; Wei T; Guo D
    Cell Signal; 2024 Feb; 114():110994. PubMed ID: 38036196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tRNA Gm18 methyltransferase TARBP1 promotes hepatocellular carcinoma progression via metabolic reprogramming of glutamine.
    Shi X; Zhang Y; Wang Y; Wang J; Gao Y; Wang R; Wang L; Xiong M; Cao Y; Ou N; Liu Q; Ma H; Cai J; Chen H
    Cell Death Differ; 2024 Jun; ():. PubMed ID: 38867004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudouridine synthase 1 promotes hepatocellular carcinoma through mRNA pseudouridylation to enhance the translation of oncogenic mRNAs.
    Hu YX; Diao LT; Hou YR; Lv G; Tao S; Xu WY; Xie SJ; Ren YH; Xiao ZD
    Hepatology; 2023 Nov; ():. PubMed ID: 38015993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGC1-mediated Metabolic Reprogramming and Autophagy Sustain Survival of Hepatocellular Carcinoma Cells under Glutamine Deprivation.
    Liu Y; Miao Z; Yang Q
    Cell Biochem Biophys; 2024 May; ():. PubMed ID: 38789662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The switch triggering the invasion process: Lipid metabolism in the metastasis of hepatocellular carcinoma.
    Zhang J; Zhang Z; Wu Z; Wang Y; Zhang Z; Xia L
    Chin Med J (Engl); 2024 May; ():. PubMed ID: 38738689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sweet dreams could be made of this: carbohydrate-responsive element-binding protein (ChREBP) as a target for hepatocellular carcinoma therapy.
    Fernández-Barrena MG; Avila MA
    Mol Oncol; 2024 Jun; ():. PubMed ID: 38837736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoproteomics Reveals USP5 (Ubiquitin Carboxyl-Terminal Hydrolase 5) as Promising Target of the Marine Polyketide Gracilioether A.
    Capuano A; D'Urso G; Aliberti M; Ruggiero D; Terracciano S; Festa C; Tosco A; Chini MG; Lauro G; Bifulco G; Casapullo A
    Mar Drugs; 2024 Jan; 22(1):. PubMed ID: 38248666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.